Insight

Feb 19, 2024, 07:14

Giselle Sholler: I am happy to share our Beat Childhood Cancer Consortium article published this week in Genome Medicine

Giselle Sholler, Division Chief Pediatric Hematology/Oncology/BMT at Penn State Health Children’s Hospital, posted on LinkedIn:

“I am happy to share our Beat Childhood Cancer Consortium article published this week in Genome Medicine “Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial” as this team leads the way in precision medicine in pediatric oncology using genomics to create personalized treatments for children with refractory cancers.”

View additional information.
Source: Giselle Sholler/LinkedIn

Beat Childhood Cancer Consortium cancer Genome Medicine Giselle Sholler Molecular-guided therapy OncoDaily Oncology pediatric oncology personalized treatments publication relapsed and refractory childhood cancers

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage